For the accuracy of the results, the study was carried out for three years. The average of each factory gins was chosen. Comparison of fiber properties processed in different cotton processing plants, with different models of fiber separators. Each sample of fiber grade 1 Namangan 77 raw cotton was obtained as a result of ginning with such factory gins 4DP-130.5 DP-130, 3HDD and Lummus gins in Namangan region. The Fiber properties of all samples were measured with the Advanced HVI Fiber Information System, to determine the yield of short fibers. The main purpose of the study is to determine which model of sawing gin to produce more short fibers. For next modernization working parts of other model gin for increasing quality of fiber.

No abstract

similar to literature. However, most of old cases, we can obtain ras mutation status after first line therapy, so in the ras wild type tumors, first line anti-EGFR usage was lower than the current practice. Despite of low-percentage of anti-EGFR usage at first line, our results showed that the pts with left-sided primary, with first line anti-EGFR treatment, median OS was 39.3 months. In the pts with right sided primary, the OS difference between first line anti-EGFR and anti-VEGF treatments were not significant.

Associated factors were analyzed by the chi-square and multiple logistic regression with SPSS 20.0 and dispersion analysis (ANOVA). Results: The overall prevalence of H. pylori infection in patients with dyspepsia was 87.6% (2189 patients) and 81% (81 patients) in control patient group with no symptoms. In a group of 126 patients (median age 64,569.8; 78 (61.9%) males and 49 (38.9%) females with newly diagnosed adenocarcinoma, in 58 (46%) the tumor was located in antrum, in 33 (26.2%) at the lesser curvature, in 13 (10.3%) at the greater curvature, in 17 (13.5%) at the cardial part and in 5 (4%) patients in the fundus. H. pylori test was positive in 52 (89.6%) of 58 patients with antral malignancy, in 29 (87.9%) of 33 patients with lesser curvature cancer, in 7 (53.8%) of 13 patients with greater curvature cancer, in 5 (29.4) of 17 patients with cardial malignancy and in 2 (40%) of 5 patients with fundus and body malignancy. Conclusion:The prevalence of H.Pylori in patients with dyspeptic symptoms is 87.6% comparing to 81% of general population. Besides age and gender predisposion, H.Pylori infection is strongly associated with the development of antral and lesser curvature adenocarcinoma comparing to cardia, fundus and greater curvature malignancy locations. (P value <0.001 in females; P value <0.007 in males).P À 060 Comparison of efficacy and safety between redo-endoscopic treatment and surgery for recurrent gastric neoplasms at the scar of endoscopic submucosal dissection

Associated factors were analyzed by the chi-square and multiple logistic regression with SPSS 20.0 and dispersion analysis (ANOVA). Results: The overall prevalence of H. pylori infection in patients with dyspepsia was 87.6% (2189 patients) and 81% (81 patients) in control patient group with no symptoms. In a group of 126 patients (median age 64,569.8; 78 (61.9%) males and 49 (38.9%) females with newly diagnosed adenocarcinoma, in 58 (46%) the tumor was located in antrum, in 33 (26.2%) at the lesser curvature, in 13 (10.3%) at the greater curvature, in 17 (13.5%) at the cardial part and in 5 (4%) patients in the fundus. H. pylori test was positive in 52 (89.6%) of 58 patients with antral malignancy, in 29 (87.9%) of 33 patients with lesser curvature cancer, in 7 (53.8%) of 13 patients with greater curvature cancer, in 5 (29.4) of 17 patients with cardial malignancy and in 2 (40%) of 5 patients with fundus and body malignancy. Conclusion: The prevalence of H.Pylori in patients with dyspeptic symptoms is 87.6% comparing to 81% of general population. Besides age and gender predisposion, H.Pylori infection is strongly associated with the development of antral and lesser curvature adenocarcinoma comparing to cardia, fundus and greater curvature malignancy locations. (P value <0.001 in females; P value <0.007 in males). P À 060 Comparison of efficacy and safety between redo-endoscopic treatment and surgery for recurrent gastric neoplasms at the scar of prior endoscopic submucosal dissection